Whalen Wealth Management Inc. Neurocrine Biosciences Inc Transaction History
Whalen Wealth Management Inc.
- $171 Billion
- Q3 2025
A detailed history of Whalen Wealth Management Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 4,462 shares of NBIX stock, worth $636,504. This represents 0.37% of its overall portfolio holdings.
Number of Shares
4,462
Previous 3,629
22.95%
Holding current value
$636,504
Previous $456 Million
37.32%
% of portfolio
0.37%
Previous 0.29%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
662Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$794 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$637 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$440 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...